Medindia
About ▼ Careers Internship MedBlog Contact us
English (US) ▼
Medindia
LOGIN REGISTER
Advertisement

Surveyed Gastroenterologists Will Treat Fewer Crohn's Disease Patients With Remicade, While the Percentage of Biologics-Treated Patients Receiving Humira Will Increase

Thursday, April 8, 2010 Medical PDA News
Advertisement
Humira Has Achieved the Most Favorable Tier Placement Among Biologics for Crohn's Disease and Ulcerative Colitis, According to a New Report from Decision Resources

For more information, contact:

Decision Resources, Inc.

Christopher Comfort

781-296-2597

[email protected]

Sponsored Post and Backlink Submission


Latest Press Release on Medical PDA News

Golden Meditech Announces the Proposed Voluntary Delisting of TDR on TWSE
Hong Kong , Oct. 30, 2017 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801, TWSE stock code: 910801) ("Golden Meditech" or the "Company", together with its s...
Access Scientific, LLC, Awarded Intalere Choice® Agreement for POWERWAND™ Line of Catheters
SAN DIEGO , Jan. 25, 2017 /PRNewswire/ -- Access Scientific, a privately held medical device manufacturer of the "evidence based, best in class" POWERWAND catheters, was awarded an ag...
Pharmacy Expert Shares Insights on New Reimbursement Programs for Medication Therapy Management Services
DUBLIN, Ohio , Nov. 6, 2015 /PRNewswire/ -- It's estimated that 1.5 million preventable, adverse medication mismanagement events occur each year that cost $177 billion and result in...
3D Signatures and CIMTEC to develop automated software for prognostic medical tests
WINNIPEG , Sept 10, 2015 /CNW/ - 3D Signatures Inc. (3D Signatures) and the Centre for Imaging Technology Commercialization (CIMTEC) have entered into an agreement to develop soft...
Southern Research and UAB Part of Multisite Study on Effects of Chemical Nerve Agents
BIRMINGHAM, Ala. , Sept. 8, 2015 /PRNewswire-USNewswire/ -- Researchers at Southern Research and the University of Alabama at Birmingham are part of a multisite consortium sharing...
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close